Loading market dashboard
IGC Pharma, Inc.
IGCHealthcareAMEXUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
IGC Pharma, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2028 | $860.0K | $860.0K - $860.0K | -$860.0K | -$0.08 | 1 |
| Mar 2027 | $860.0K | $860.0K - $860.0K | -$860.0K | -$0.08 | 1 |
| Mar 2026 | $869.0K | $869.0K - $869.0K | -$869.0K | -$0.05 | 1 |
| Mar 2025 | $1.25M | $1.25M - $1.25M | -$1.25M | -$0.10 | 1 |
| Mar 2024 | $1.06M | $1.06M - $1.06M | -$1.06M | -$0.209 | 1 |
| Mar 2023 | $22.20M | $21.16M - $23.24M | -$22.20M | $0.42 | 1 |
| Mar 2022 | $11.40M | $10.87M - $11.93M | -$11.40M | $0.09 | 1 |
| Mar 2016 | $22.20M | $21.16M - $23.24M | -$22.20M | $0.42 | 1 |
| Mar 2015 | $11.40M | $10.87M - $11.93M | -$11.40M | $0.09 | 1 |